Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

569
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
569
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

524
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
524
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

1.5K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.5K
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

538
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
538
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

280
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
280
Personality Disorders: Paranoid and Schizoid01:22

Personality Disorders: Paranoid and Schizoid

321
Personality disorders represent enduring cognition, affect, and behavior patterns that significantly deviate from societal norms. These maladaptive traits often lead to difficulties in various domains, including interpersonal relationships, occupational settings, and overall psychological well-being. Paranoid personality disorder and schizoid personality disorder are two distinct conditions marked by odd or eccentric behavior.
Paranoid Personality Disorder
Paranoid personality disorder is...
321

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Very slow atrioventricular nodal reentry masquerading as junctional rhythm: Diagnostic challenges and mechanistic insights.

Heart rhythm·2025
Same author

Editorial: 8th biennial international drug and alcohol research society conference 2022.

Advances in drug and alcohol research·2025
Same author

Isolated Abducens Nerve Palsy: A Rare Manifestation of Recurrent Extramedullary Myeloma.

Journal of radiology case reports·2024
Same author

Alcohol induced behavioral and immune perturbations are attenuated by activation of CB2 cannabinoid receptors.

Advances in drug and alcohol research·2024
Same author

Cannabinoid CB2 receptors and hypersensitivity to methamphetamine: Vulnerability to schizophrenia.

Progress in neuro-psychopharmacology & biological psychiatry·2023
Same author

Acute cannabidiol treatment enhances social interaction in adult male mice.

Advances in drug and alcohol research·2023

Related Experiment Video

Updated: Nov 25, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.2K

Psychiatric Disorders and Cannabinoid Receptors.

Neal Joshi1, Emmanuel S Onaivi2

  • 1Rowan University School of Osteopathic Medicine, Stratford, NJ, USA.

Advances in Experimental Medicine and Biology
|December 17, 2020
PubMed
Summary

Cannabis use impacts the endocannabinoid system (ECS), potentially worsening psychiatric disorders. Research highlights the need for treatments for cannabis use disorders (CUDs) and explores nanotechnology for cannabinoid therapies.

Keywords:
Cannabinoid receptorsCannabinoidsCannabisEndocannabinoid systemEndocannabinoidsPsychiatric disorders

More Related Videos

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

556
Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

938

Related Experiment Videos

Last Updated: Nov 25, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.2K
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

556
Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

938

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Global increase in medical and recreational cannabis use.
  • Cannabis and cannabinoids interact with the endocannabinoid system (ECS).
  • ECS components, including CB1Rs and CB2Rs, are implicated in psychiatric disorders.

Purpose of the Study:

  • To review evidence on the relationship between the ECS and psychiatric disorders.
  • To evaluate the role of cannabinoid receptors in CNS and PNS.
  • To identify knowledge gaps and future research directions in cannabis and ECS research.

Main Methods:

  • Review of animal and human studies.
  • Evaluation of existing scientific literature on ECS and psychiatric disorders.
  • Analysis of cannabinoid receptor expression and function.

Main Results:

  • Evidence suggests a link between ECS alterations and psychiatric disorder symptoms.
  • CB1Rs and CB2Rs are potential therapeutic targets for psychiatric conditions.
  • Cannabis use disorders (CUDs) are increasing with no current treatments.

Conclusions:

  • Further research is needed on long-term cannabis use consequences, especially in adolescents and during pregnancy.
  • Understanding gut microbiota-ECS interactions is crucial.
  • Nanotechnology offers potential for targeted cannabinoid delivery and nanotherapeutic applications.